Skip to main content
Type at least 3 characters

921 articles

Original Research

Published on 08 Feb 2024

ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

  • Afsaneh Barzi
  • Caroline M. Weipert
  • Carin R. Espenschied
  • Victoria M. Raymond
  • Andrea Wang-Gillam
  • Mohammad Amin Nezami
  • Eva J. Gordon
  • Daruka Mahadevan
  • Kabir Mody
Frontiers in Oncology
doi 10.3389/fonc.2024.1339302
  • 4,199 views
  • 2 citations